Clarivate for Life Sciences & Healthcare

Join Clarivate experts Madhurima Datta, Reena V Gupta, Soumik Das, Manushi Vachhrajani, Ramandeep Singh at CPHI India 2024, now through November 28 in Delhi. This is your chance to meet with our team and explore emerging trends in the pharmaceutical industry. Connect with leading experts, discuss collaboration opportunities and discover how Clarivate's transformative data can shape the future of the pharma world. Learn how our market-leading intelligence and transformative data technology can shape the industry’s trajectory. Book a meeting with our team here: https://lnkd.in/eq3kbvT4 #CPhIIndia #Pharmaceuticals #Networking #Innovation #Collaboration #pharma

Thank you to everyone who connected with us at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024 in Barcelona. The event provided an excellent opportunity to engage with healthcare leaders, researchers, and policymakers from across the globe, driving forward important conversations in Health Economics and Outcomes Research (HEOR). Our team— Alison Isherwood, Brigitte Moore, Catherine Bottomley, Ciaran Cassidy, Ilias Paniaras, Nicki Hoskins, Richard Massey, Sarah Knight, Sonia Alesso, Stacey Chang-Douglass, and Sunita Nair—was delighted to share insights on the latest trends shaping the future of healthcare. During the conference, Alison, Brigitte, Catherine, Nicki, Stacey, and Sunita presented their research during the poster sessions adding invaluable insight to the on-going discussion of patient outcomes and healthcare value. Clarivate presentations highlighted diverse topics, including the use of qualitative research to identify key patient concepts, incorporating broader perspectives in health economic evaluations and AI-assisted reviews of NICE guidance for ultra-rare conditions. Discussions also explored the clinical, economic and humanistic burden of SIDS/SUID, risk factors for psoriasis, gene therapies for gliomas and the challenges of clinical endpoint heterogeneity in Crohn’s disease and ulcerative colitis. Navigate the evolving regulatory and commercial landscape with the support of our experts. Connect with the team here: https://lnkd.in/eFUWW4qi #HealthcareInnovation #HEOR #HealthEconomics #Networking #ISPOR2024 #GlobalHealth #HealthWellBeing

At the 2nd Pujiang Biopharmaceutical Original Innovation Forum, hosted by the Shanghai Biopharmaceutics Industry Association and co-organized by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Andrew O'Brien, Vice President, Life Sciences and Healthcare APAC at Clarivate, provided key insights on the growing emphasis of leading pharmaceutical companies on precision medicine and real-world data. Andrew highlighted the dynamic collaboration between pharmaceutical enterprises, universities, and R&D institutions, showcasing how innovation and R&D partnerships are increasingly shaped by evolving data trends. As global data mining accelerates, it is fueling drug innovation with a sharper focus on meeting clinical needs. By harnessing data to develop more efficient and precise treatment strategies, the pharmaceutical industry is advancing its ability to address unmet clinical challenges and improve patient outcomes. #PrecisionMedicine #RealWorldData #Pharmaceutical #Innovation #DataDriven

In 2023, just 15% of venture capital funding was directed to biopharma companies focused on women’s health, and only 8% of funded companies included women’s health assets in their pipelines. These disparities leave critical gaps in care for conditions from Alzheimer’s disease to endometriosis, yet often goes undiagnosed for years. BioWorld News by?Clarivate has launched a new special series, ‘Healing the Health Divide.’ This seven-part series sheds light on the persistent disparities in women’s health research, funding and treatment. Lynn Yoffee, Publisher of BioWorld, stated: “This series not only exposes the disparities but also celebrates the progress being made, with the goal of inspiring industry leaders and scientists to close these gaps and create solutions that benefit all of humanity.” Learn more, here: https://ow.ly/c7l650Ubvj4 #WomensHealth #HealthEquity #BioPharma #innovation

Pulsed field ablation (PFA) is a breakthrough technology for the treatment of atrial fibrillation (AF). Its adoption is being propelled by positive clinical data from several trials, including the pivotal ADVENT trial, which showed that PFA reduced procedure times and complications with comparable efficacy to thermal ablation. Read more on key cardiovascular market trends here: https://lnkd.in/ddTJy5NA #CardioVascular #MedtechInsights #MedicalDevices

Join Clarivate experts Madhurima Datta, Reena V Gupta, Soumik Das, Manushi Vachhrajani, Ramandeep Singh at CPHI India 2024, where industry innovation aligns with opportunity from November 26-28 in Delhi. Meet with our team to explore emerging trends, connect with industry leaders and discuss opportunities for collaboration to drive the future of pharmaceuticals. Learn how Clarivate’s market-leading intelligence and transformative data technology can shape the industry’s trajectory. Book a meeting with our team here: https://lnkd.in/eq3kbvT4 #CPhIIndia #Pharmaceuticals #Networking #Innovation #Collaboration #pharma

As atrial fibrillation (AF) cases are expected to double over the next 25 years, PFA is emerging as a game-changer in the treatment of this life-threatening condition. By using high-voltage electrical pulses instead of thermal energy, PFA offers a safer, faster procedure with lower recurrence rates and fewer complications compared to traditional thermal ablation methods like cryoablation and RF. This breakthrough technology has already ignited rapid adoption worldwide, expanding the pool of eligible patients and driving growth in the cardiac ablation market. With PFA, patients experience reduced risks of damaging vital tissues—like the pulmonary vein and esophagus—while achieving higher success rates and fewer device-related complications. This makes PFA an appealing alternative to traditional ablation, offering hope for better outcomes and fewer lifelong medication dependencies for millions of AF patients. Stay tuned for the latest Clarivate Pulsed field ablation report taking a closer look at the stunning growth shocks the atrial fibrillation market: https://lnkd.in/eWACgydi #PFA #PulsedFieldAblation #Cardiovascular

How is Mainland China Redefining Biopharmaceutical Innovation? In just a decade, Mainland China has transformed into a global leader in biopharmaceutical innovation. With reforms that accelerate approvals, elevate regulatory standards, and expand patient access, alongside a 3.5x surge in R&D investment, the nation is setting new benchmarks in healthcare. Insights from the Institute for Scientific Information? show that these advancements are empowering companies to bring life-changing therapies to market faster—improving outcomes for millions. Authored by Alice Zeng (曾亚莉), Shuxin Bao, Fanney Wu, Boya Z. and Mike Ward, our latest report, "A Decade of Innovation, A Decade to Come," created in partnership with Healthcare Executive, dives into the policies, investments and global opportunities fueling this remarkable transformation. Explore how these trends are shaping the future of healthcare and driving a new era of innovation. Download the report now: https://lnkd.in/eT4rSFGX #Biopharma #Healthcare #China #research #Pharmaceuticals #MedicalInnovation #Clarivate #HealthTech

Thank you for joining the Clarivate team at the 16th China Healthcare Summit of Entrepreneurs, Scientists, and Investors (CHSESI) from November 13-15 in Chengdu. The event brought together over 1,000 industry leaders, fostering meaningful discussions on the future of healthcare. The Clarivate team—Xiaoxia Sun, Amanda Zhou, Huan Gu, 吴燕妮, Edward Y., Junda (Mark) Yan, and Lulice Zhao—was pleased to connect with industry stakeholders to discuss insights on the latest trends shaping the pharmaceutical industry. During the summit, Clarivate shared a new report, "A Decade of Innovation, A Decade to Come" report, developed in collaboration with Healthcare Executive. This report celebrates the achievements of China’s biopharmaceutical sector and provides forward-looking insights into its continued evolution. Download the report here: https://lnkd.in/e8zv77kN #HealthcareInnovation #PharmaIndustry #Clarivate #DataSolutions #CHSESI2024

We’re at the ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024, now through November 20 in Barcelona. This year’s theme, “Generating Evidence Toward Health and Well-Being," will focus on the critical role of scientific evidence in improving global health and well-being. Our experts — Alison Isherwood, Brigitte Moore, Catherine Bottomley, Ciaran Cassidy, Ilias Paniaras, Nicki Hoskins, Richard Massey, Sarah Knight, Sonia Alesso, Stacey Chang-Douglass, and Sunita Nair — will be on hand to discuss the latest trends and innovations in Health Economics and Outcomes Research (HEOR). @Alison, Brigitte, Catherine, Nicki, Stacey, and Sunita will present their latest research during poster sessions—stay tuned for more details. Connect with our team to book a meeting or visit booth 701. #HealthcareInnovation #HEOR #HealthEconomics #Networking #ISPOR2024